197 related articles for article (PubMed ID: 33332878)
1. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
Leitao Filho FS; Choi L; Sin DD
Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878
[TBL] [Abstract][Full Text] [Related]
2. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
Mersfelder TL; Shiltz DL
Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
[No Abstract] [Full Text] [Related]
3. Beta-blockers in COPD: time for reappraisal.
Lipworth B; Wedzicha J; Devereux G; Vestbo J; Dransfield MT
Eur Respir J; 2016 Sep; 48(3):880-8. PubMed ID: 27390282
[TBL] [Abstract][Full Text] [Related]
4. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
Short PM; Lipworth SI; Elder DH; Schembri S; Lipworth BJ
BMJ; 2011 May; 342():d2549. PubMed ID: 21558357
[TBL] [Abstract][Full Text] [Related]
5. Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
Neef PA; Burrell LM; McDonald CF; Irving LB; Johnson DF; Steinfort DP
Intern Med J; 2017 Sep; 47(9):1043-1050. PubMed ID: 28608512
[TBL] [Abstract][Full Text] [Related]
6. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
7. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
[TBL] [Abstract][Full Text] [Related]
8. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
[TBL] [Abstract][Full Text] [Related]
9. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
[TBL] [Abstract][Full Text] [Related]
10. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
[TBL] [Abstract][Full Text] [Related]
11. Use of beta-blockers in patients with COPD.
Andrus MR; Holloway KP; Clark DB
Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
[TBL] [Abstract][Full Text] [Related]
12. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ
Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016
[TBL] [Abstract][Full Text] [Related]
13. Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.
Dong YH; Chang CH; Wu LC; Lai MS
Eur J Clin Pharmacol; 2016 Oct; 72(10):1265-1273. PubMed ID: 27444174
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) - Study protocol from a randomized controlled trial.
Sundh J; Magnuson A; Montgomery S; Andell P; Rindler G; Fröbert O;
Trials; 2020 Jan; 21(1):123. PubMed ID: 32000825
[TBL] [Abstract][Full Text] [Related]
15. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
Mtisi TF; Frishman WH
Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
[TBL] [Abstract][Full Text] [Related]
16. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
17. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
Glaab T; Weiss T
Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
[TBL] [Abstract][Full Text] [Related]
18. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
[TBL] [Abstract][Full Text] [Related]
19. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
20. Can beta-blockers be used for people with COPD?
Drug Ther Bull; 2011 Jan; 49(1):2-5. PubMed ID: 21220252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
